MCL1 and central nervous system cancer: We examined both Pol II Ser2 phosphorylation, the primary catalytic output of P-TEFb21, as well as MCL1 expression, a rapid-turnover anti-apoptotic protein with established P-TEFb-dependence59, over time following AZD4573 treatment in both glioma and normal astrocyte cultures.